1
|
Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study.
|
JAMA
|
2000
|
6.37
|
2
|
Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.
|
J Natl Cancer Inst
|
2000
|
4.89
|
3
|
Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study.
|
J Natl Cancer Inst
|
2001
|
3.00
|
4
|
Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study.
|
J Natl Cancer Inst
|
1999
|
2.59
|
5
|
Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study.
|
J Natl Cancer Inst
|
2001
|
2.09
|
6
|
An evaluation of a food frequency questionnaire for assessing dietary intake of specific carotenoids and vitamin E among low-income black women.
|
Am J Epidemiol
|
1991
|
1.92
|
7
|
Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: results from the Prostate Cancer Outcomes Study.
|
J Clin Oncol
|
2001
|
1.86
|
8
|
Differences between black and white women with breast cancer in time from symptom recognition to medical consultation. Black/White Cancer Survival Study Group.
|
J Natl Cancer Inst
|
1992
|
1.77
|
9
|
Predicting extracapsular extension of prostate cancer in men treated with radical prostatectomy: results from the population based prostate cancer outcomes study.
|
J Urol
|
1999
|
1.56
|
10
|
Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study.
|
J Clin Oncol
|
2001
|
1.46
|
11
|
Validation study of retrospective recall of disease-targeted function: results from the prostate cancer outcomes study.
|
Med Care
|
2000
|
1.36
|
12
|
Race, nutritional status, and survival from breast cancer.
|
J Natl Cancer Inst
|
1990
|
1.23
|
13
|
Histological characteristics of breast carcinoma in blacks and whites.
|
Cancer Epidemiol Biomarkers Prev
|
1994
|
1.22
|
14
|
Racial differences in endometrial cancer survival: the black/white cancer survival study.
|
Obstet Gynecol
|
1996
|
1.16
|
15
|
Treatment plans for black and white women with stage II node-positive breast cancer. The National Cancer Institute Black/White Cancer Survival Study experience.
|
Cancer
|
1992
|
1.06
|
16
|
Nosocomial fungemia in neonates associated with intravascular pressure-monitoring devices.
|
Pediatr Infect Dis
|
1987
|
1.04
|
17
|
Endometrial cancer: stage at diagnosis and associated factors in black and white patients.
|
Am J Obstet Gynecol
|
1995
|
1.00
|
18
|
Dietary glutathione intake in humans and the relationship between intake and plasma total glutathione level.
|
Nutr Cancer
|
1994
|
0.98
|
19
|
Glutathione in foods listed in the National Cancer Institute's Health Habits and History Food Frequency Questionnaire.
|
Nutr Cancer
|
1992
|
0.91
|
20
|
Differences between black and white patients with cancer of the uterine corpus in interval from symptom recognition to initial medical consultation (United States).
|
Cancer Causes Control
|
1996
|
0.91
|
21
|
Plasma total glutathione in humans and its association with demographic and health-related factors.
|
Br J Nutr
|
1993
|
0.90
|
22
|
Non-Hodgkin's lymphomas in patients with human immunodeficiency virus infection. Presence of Epstein-Barr virus by in situ hybridization, clinical presentation, and follow-up.
|
Cancer
|
1991
|
0.80
|
23
|
Case-control assessment of the association between non-Hodgkin's lymphoma and occupational radiation with doses assessed using a job exposure matrix.
|
Am J Ind Med
|
2000
|
0.77
|
24
|
Cine-MRI-aided endomyocardectomy in idiopathic hypereosinophilic syndrome.
|
Ann Thorac Surg
|
1996
|
0.77
|
25
|
Linking health services research to education at an academic health center.
|
Acad Med
|
1996
|
0.75
|
26
|
Analyzing costs and benefits of mammography screening in the workplace.
|
AAOHN J
|
1989
|
0.75
|
27
|
A survey of alcohol use in an inner-city ambulatory care setting.
|
J Gen Intern Med
|
1991
|
0.75
|
28
|
High dose cyclophosphamide, fractionated total body irradiation with involved field irradiation and autologous bone marrow transplantation in malignant lymphoma.
|
Leuk Lymphoma
|
1996
|
0.75
|